Roche Holding (RHHBY)
(Delayed Data from OTC)
$39.97 USD
+0.47 (1.18%)
Updated Sep 24, 2024 02:24 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Roche Holding AG falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 11,707 | 10,235 | 14,257 | 13,155 | 11,935 |
Receivables | 12,276 | 12,162 | 11,823 | 10,830 | 10,508 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 8,632 | 9,017 | 8,441 | 7,673 | 6,094 |
Other Current Assets | 4,641 | 4,022 | 4,458 | 3,477 | 2,920 |
Total Current Assets | 37,256 | 35,436 | 38,980 | 35,136 | 31,457 |
Net Property & Equipment | 24,198 | 24,180 | 25,343 | 23,634 | 22,317 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 7,666 | 6,735 | 6,108 | 5,823 | 5,245 |
Intangibles | 26,976 | 21,487 | 25,083 | 22,682 | 20,949 |
Deposits & Other Assets | 3,323 | 3,348 | 4,124 | 3,414 | 2,510 |
Total Assets | 100,772 | 92,373 | 101,004 | 91,875 | 83,631 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4,818 | 4,774 | 5,073 | 4,395 | 3,847 |
Current Portion Long-Term Debt | 4,901 | 4,150 | 16,545 | 4,262 | 1,706 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 2,514 | 3,340 | 3,284 | 3,924 | 3,863 |
Other Current Liabilities | 15,419 | 16,280 | 17,128 | 14,511 | 14,860 |
Total Current Liabilities | 27,651 | 28,544 | 42,031 | 27,093 | 24,276 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 661 | 676 | 687 | 377 | 300 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 27,635 | 22,416 | 17,589 | 10,901 | 12,750 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7,774 | 7,190 | 9,685 | 11,083 | 10,205 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 63,721 | 58,825 | 69,992 | 49,453 | 47,531 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 119 | 112 | 175 | 171 | 161 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 47,170 | 40,802 | 37,376 | 48,606 | 40,787 |
Other Equity | -10,238 | -7,366 | -6,538 | -6,355 | -4,848 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 37,052 | 33,549 | 31,012 | 42,422 | 36,100 |
Total Liabilities & Shareholder's Equity | 100,772 | 92,373 | 101,004 | 91,875 | 83,631 |
Total Common Equity | 37,052 | 33,549 | 31,012 | 42,422 | 36,100 |
Shares Outstanding | NA | 6,830.00 | 6,830.00 | 6,848.40 | 6,848.40 |
Book Value Per Share | -0.37 | 4.91 | 4.54 | 6.19 | 5.27 |
Fiscal Year End for Roche Holding AG falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 11,707 | -99,999 | 8,353 |
Receivables | NA | NA | 12,276 | NA | 12,335 |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | NA | NA | 8,632 | NA | 9,451 |
Other Current Assets | NA | NA | 4,641 | NA | 4,318 |
Total Current Assets | NA | NA | 37,256 | NA | 34,458 |
Net Property & Equipment | NA | NA | 24,198 | NA | 25,354 |
Investments & Advances | NA | NA | 0 | NA | NA |
Other Non-Current Assets | NA | NA | 0 | NA | NA |
Deferred Charges | NA | NA | 7,666 | NA | 7,416 |
Intangibles | NA | NA | 26,976 | NA | 21,906 |
Deposits & Other Assets | NA | NA | 3,323 | NA | 3,492 |
Total Assets | NA | NA | 100,772 | NA | 93,853 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | NA | NA |
Accounts Payable | NA | NA | 4,818 | NA | 4,511 |
Current Portion Long-Term Debt | NA | NA | 4,901 | NA | 5,608 |
Current Portion Capital Leases | NA | NA | 0 | NA | NA |
Accrued Expenses | NA | NA | 0 | NA | NA |
Income Taxes Payable | NA | NA | 2,514 | NA | 3,978 |
Other Current Liabilities | NA | NA | 15,419 | NA | 15,057 |
Total Current Liabilities | NA | NA | 27,651 | NA | 29,154 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | NA | NA | 661 | NA | 746 |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | NA | NA | 27,635 | NA | 22,632 |
Non-Current Capital Leases | NA | NA | 0 | NA | NA |
Other Non-Current Liabilities | NA | 7,774 | NA | 7,567 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | NA | NA | 63,721 | NA | 60,099 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | NA | NA | 119 | NA | 119 |
Capital Surplus | NA | NA | 0 | NA | NA |
Retained Earnings | NA | NA | 47,170 | NA | 42,642 |
Other Equity | NA | NA | -10,238 | NA | -9,006 |
Treasury Stock | NA | NA | 0 | NA | NA |
Total Shareholder's Equity | NA | NA | 37,052 | NA | 33,755 |
Total Liabilities & Shareholder's Equity | NA | NA | 100,772 | NA | 93,853 |
Total Common Equity | 0 | 0 | 37,052 | 0 | 133,754 |
Shares Outstanding | NA | NA | NA | NA | 6,830.00 |
Book Value Per Share | 0.00 | 0.00 | -0.37 | 0.00 | 19.58 |